|Table of Contents|

Research Progress of Soy Isoflavones and Equol Based on Analyzing the Literatues Published in CNKI and PubMed Database(PDF)

《大豆科学》[ISSN:1000-9841/CN:23-1227/S]

Issue:
2019年01期
Page:
134-141
Research Field:
Publishing date:

Info

Title:
Research Progress of Soy Isoflavones and Equol Based on Analyzing the Literatues Published in CNKI and PubMed Database
Author(s):
CHEN Hua-hai;  TAN Li-rui;  HU Yun-fei;  CAO Lin-yan;  YIN Ye-shi
(College of Chemistry and Bioengineering/Key Laboratory of Comprehensive Utilization of Advantage Plants Resources in Hunan South, Hunan University of Science and Engineering, Yongzhou 425199, China)
Keywords:
Soy isoflavones;  Equol;  CNKI;  PubMed;  Literature analysis
PACS:
-
DOI:
10.11861/j.issn.1000-9841.2019.01.0134
Abstract:
To analyze the published journal papers and to understand the latest research progress of soybean isoflavones and estradiol can provide help and reference for further research and product upgrading of soybean isoflavones. Data from CNKI database and PubMed online analysis website was downloaded for literature analysis with the theme of ‘soy isoflavones’ or ‘equol’. We used Excelto analysisdata, preparate table and chartion. Soybean isoflavones and equol were mainly published in the journals of ‘Soybean Science’, ‘Journal of Hygiene Research’ and ‘The Journal of Nutrition’. They were mostly distributed in the fields of preventive medicine, food nutrition and hygiene, biology, pharmacy and oncology. The Chinese literature mainly focuses on extraction, purification and detection methods research, while the foreign literature reportsare related to tumors, breast cancer, nutritional and metabolic diseases. The United States, China and Japan are the main countries publishing soy isoflavones and equol literature, but from the perspective of research institutions, the research focus of each research unit is somewhat different. It is worth pondering that after 2007, the article numbers of soy isoflavones and equol has decreased dramatically. Although soy isoflavones have been studied for many years, there are few studies on equol, and further studies are needed to improve the nutritional and economic value of traditional soybean food.

References:

［1］卢丞文, 刘颖. 大豆异黄酮生理功能的研究进展［J］. 农业与技术, 2017, 37(17):4-5. (Lu Z W, Liu Y. Research progress on physiological function of soybean isoflavones［J］. Agriculture and Technology, 2017, 37(17):4-5.)
［2］Messina M, Rogero M M, Fisberg M, et al. Health impact of childhood and adolescent soy consumption［J］. Nutrition Reviews, 2017, 75(7):500-515.
［3］Zaheer K, Humayoun A M. An updated review of dietary isoflavones: Nutrition, processing, bioavailability and impacts on human health［J］. Critical Reviews in Food Science and Nutrition, 2017, 57(6):1280-1293.
［4］Setchell K D, Brown N M, Zimmer-Nechemias L, et al. Evidence for lack of absorption of soy isoflavone glycosides in humans, supporting the crucial role of intestinal metabolism for bioavailability［J］. The American Journal of Clinical Nutrition, 2002, 76(2):447-453.
［5］Nakajima N, Nozaki N, Ishihara K, et al. Analysis of isoflavone content in tempeh, a fermented soybean, and preparation of a new isoflavone-enriched tempeh［J］. Journal of Bioscience and Bioengineering, 2005, 100(6):685-687.
［6］Frankenfeld C L. Cardiometabolic risk and gut microbial phytoestrogen metabolite phenotypes［J］. Molecular Nutrition & Food Research, 2017, 61(1), Doi: 10.1002/mnfr.201500900.
［7］Setchell K D, Clerici C. Equol: History, chemistry, and formation［J］. The Journal of Nutrition, 2010, 140(7):1355-1362.
［8］Setchell K D, Brown N M, Lydeking-Olsen E. The clinical importance of the metabolite equol-a clue to the effectiveness of soy and its isoflavones［J］. The Journal of Nutrition, 2002, 132(12):3577-3584.
［9］Setchell K D, Clerici C. Equol: Pharmacokinetics and biological actions［J］. The Journal of Nutrition, 2010, 140(7):1363-1368.
［10］Bowey E, Adlercreutz H, Rowland I. Metabolism of isoflavones and lignans by the gut microflora: A study in germ-free and human flora associated rats［J］. Food and Chemical Toxicology, 2003, 41(5):631-636.
［11］Rowland I, Wiseman H, Sanders T, et al. Metabolism of oestrogens and phytoestrogens: Role of the gut microflora［J］. Biochemical Society Transactions, 1999, 27(2):304-308.
［12］Setchell K D, Zhao X, Shoaf S E, et al. The pharmacokinetics of S-(-)equol administered as SE5-OH tablets to healthy postmenopausal women［J］. The Journal of Nutrition, 2009, 139(11):2037-2043.
［13］Setchell K D, Cole S J. Method of defining equol-producer status and its frequency among vegetarians［J］. The Journal of Nutrition, 2006, 136(8):2188-2193.
［14］Rowland I R, Wiseman H, Sanders T A, et al. Interindividual variation in metabolism of soy isoflavones and lignans: Influence of habitual diet on equol production by the gut microflora［J］. Nutrition and Cancer, 2000, 36(1):27-32.
［15］Song K B, Atkinson C, Frankenfeld C L, et al. Prevalence of daidzein-metabolizing phenotypes differs between Caucasian and Korean American women and girls［J］. The Journal of Nutrition, 2006, 136(5):1347-1351.
［16］Xiao Y, Zhang S, Tong H, et al. Comprehensive evaluation of the role of soy and isoflavone supplementation in humans and animals over the past two decades［J］. Phytotherapy Research, 2018, 32(3):384-394.
［17］李海亮, 邓颖, 王欣, 等. 肠道微生物代谢产物-S-雌马酚与人类健康关系研究进展［J］. 中国微生态学杂志, 2018, 30(3):362-367. (Li H L, Deng Y, Wang X, et al. The relationship between S-equol and human health: Research progress［J］. Chinese Journal of Microecology, 2018, 30(3):362-367.)

Memo

Memo:
-
Last Update: 2019-01-22